95764-37-7

Basic information

• Product Name: Carbamic acid, [5-[[2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl]amino]pentyl]-, phenylmethyl ester, (E)-
• CAS NO: 95764-37-7
• Molecular Formula: C35H37ClN2O3
• Molecular Weight: 569.143
• Mol File: 95764-37-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [5-[[2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl]amino]pentyl]-, phenylmethyl ester, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [5-[[2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl]amino]pentyl]-, phenylmethyl ester, (E)-(95764-37-7)
• EPA Substance Registry System: Carbamic acid, [5-[[2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl]amino]pentyl]-, phenylmethyl ester, (E)-(95764-37-7)

Safety Data

• Hazardous Substances Data: 95764-37-7(Hazardous Substances Data)

Upstream product

• 1137-42-4 4-Hydroxybenzophenone 
• 95764-33-3 1-<4-(2-bromoethoxy)phenyl>-1,2-diphenylethanol 
• 95764-34-4 (Z/E)-1-<4-(2-bromoethoxy)phenyl>-1,2-diphenyl ethene 
• 38459-64-2 (4-(2-bromoethoxy)phenyl)(phenyl)methanone 
• 69747-36-0 (5-aminopentyl)carbamic acid benzyl ester 
• 80867-18-1 (E)-1-<4-(2-bromoethoxy)phenyl>-2-chloro-1,2-diphenylethylene 

Downstream Products

• 95764-44-6 (E)-1-<4-<<3-aza-8-(benzyloxycarboxamido)-3-(tert-butyloxycarbonyl)octamethylene>oxy>phenyl>-2-chloro-1,2-diphenylethylene 
• 95764-38-8 (E)-1-<4-<(8-amino-3-azaoctamethylene)oxy>phenyl>-2-chloro-1,2-diphenylethylene dihydrobromide 
• 95764-47-9 (E)-1-<4-<<3-aza-8-(chloroacetamido)-3-(tert-butyloxycarbonyl)octamethylene>oxy>phenyl>-2-chloro-1,2-diphenylethylene 
• 95764-39-9 (E)-1-<4-<<3-aza-8-(chloroacetamido)-3-(chloroacetyl)octamethylene>oxy>phenyl>-2-chloro-1,2-diphenylethylene 
• 95764-45-7 (E)-1-<4-<<8-amino-3-aza-3-(tert-butyloxycarbonyl)octamethylene>oxy>phenyl>-2-chloro-1,2-diphenylethylene 
• 95764-41-3 (E)-1-<4-<<3-aza-8-(benzyloxycarboxamido)-3-(chloroacetyl)octamethylene>oxy>phenyl>-2-chloro-1,2-diphenylethylene 

Relevant articles and documents

Ellipticine Derivatives with an Affinity to the Estrogen Receptor, an Approach to Develop Intercalating Drugs with a Specific Effect on the Hormone-Dependent Breast Cancer

In order to obtain breast tumor directed agents, we have prepared mixed compounds using estradiol or (E)-clomiphene as specific vectors for the breast tissue and a DNA intercalator from the ellipticine series as cytotoxic agent.Among the newly synthesized